Innovation Pharmaceuticals Inc (IPIX)

[georgejjl]

Obviously, the new COO was misquoted.

I am sure that what he meant to say was:

"..."I believe the safety profile of Kevetrin has been very well evaluated in the current trial and is reassuring when Kevetrin is used in combination with other therapy and potentially as a single agent...."

If you don't believe me, then email him yourself.

Kevetrin has not shown sufficient activity as a single agent to warrant FDA approval as a single agent.

Good luck and GOD bless,

George